open angle glaucoma frank j. weinstock, md, facs professor of ophthalmology- neoucom canton, ohio...
TRANSCRIPT
OPEN ANGLE OPEN ANGLE GLAUCOMAGLAUCOMA
Frank J. WeinstockFrank J. Weinstock, MD, , MD, FACSFACS
Professor of Ophthalmology- Professor of Ophthalmology- NEOUCOMNEOUCOM
Canton, OhioCanton, OhioUSAUSA
TYPES OF GLAUCOMATYPES OF GLAUCOMA
PRIMARY CHRONIC SIMPLE OPEN PRIMARY CHRONIC SIMPLE OPEN ANGLEANGLE
ANGLE CLOSURE- NARROW ANGLEANGLE CLOSURE- NARROW ANGLE SECONDARYSECONDARY TRAUMATICTRAUMATIC
PRIMARY CHRONIC PRIMARY CHRONIC SIMPLE OPEN ANGLE SIMPLE OPEN ANGLE
GLAUCOMAGLAUCOMA SERIES OF CONDITIONSSERIES OF CONDITIONS OPTIC NERVE AND VISUAL FIELD OPTIC NERVE AND VISUAL FIELD
LOSS SECONDARY TO ELEVATED LOSS SECONDARY TO ELEVATED INTRAOCULAR PRESSURE OR POOR INTRAOCULAR PRESSURE OR POOR NUTRITION TO OPTIC NERVENUTRITION TO OPTIC NERVE
ETIOLOGY- NOT TRULY KNOWNETIOLOGY- NOT TRULY KNOWN
OPEN ANGLE GLAUCOMAOPEN ANGLE GLAUCOMA US- 2.2 MILLION (3.4 MILLION BY US- 2.2 MILLION (3.4 MILLION BY
2020)2020) 175000 IN US BLIND (10% OF 175000 IN US BLIND (10% OF
BLINDNESS)BLINDNESS) BLACKS-HISPANICS (30% OF BLACKS-HISPANICS (30% OF
BLINDNESS)BLINDNESS) 1 IN 1000 OVER 40 YR OLD- BLIND1 IN 1000 OVER 40 YR OLD- BLIND OVER 75 YEARS- 2.7/1000 BLIND OVER 75 YEARS- 2.7/1000 BLIND
(6.7/1000 VISUALLY IMPAIRED)(6.7/1000 VISUALLY IMPAIRED)
COMPLIANCECOMPLIANCE SCREENING $60/SCREENING AND SCREENING $60/SCREENING AND
$1000/CASE DISCOVERED$1000/CASE DISCOVERED (SCREEN HIGH RISK-RELATIVES-(SCREEN HIGH RISK-RELATIVES-
AFRICAN AMERICANS-HISPANICS-)AFRICAN AMERICANS-HISPANICS-) 25-40% OF PTS. TAKING Rx TO 25-40% OF PTS. TAKING Rx TO
STORE- DON’T PICK IT UPSTORE- DON’T PICK IT UP 60% PICKING UP Rx D/C XALATAN 60% PICKING UP Rx D/C XALATAN
DURING YR AND 76% WITH OTHER DURING YR AND 76% WITH OTHER MEDSMEDS
DIAGNOSISDIAGNOSIS OPTIC NERVE FIBER EVALUATION OPTIC NERVE FIBER EVALUATION
(OPHTHALMOCSCOPE)(OPHTHALMOCSCOPE) VISUAL FIELD EVALUATION- OFFICEVISUAL FIELD EVALUATION- OFFICE OPTIC NERVE IMAGING AND OPTIC NERVE IMAGING AND
ANALYSIS- OFFICEANALYSIS- OFFICE MEASUREMENT OF INTRAOCULAR MEASUREMENT OF INTRAOCULAR
PRESSURE (PORTABLE)PRESSURE (PORTABLE) MEASUREMENT OF CORNEAL MEASUREMENT OF CORNEAL
THICKNESSTHICKNESS GENETIC PREDISPOSITION ????GENETIC PREDISPOSITION ????
SCREENINGSCREENING
OPTIC NERVE EVALUATION- OPTIC NERVE EVALUATION- OPHTHALMOLOSCOPEOPHTHALMOLOSCOPE
INTRAOCULAR PRESSURE INTRAOCULAR PRESSURE (IOP) MEASUREMENT- (IOP) MEASUREMENT- APPLANATION TYPE APPLANATION TYPE TONOMETER TONOMETER
IOP HAS DIURNAL VARIATIONIOP HAS DIURNAL VARIATION
GOALS OF SCREENINGGOALS OF SCREENING EDUCATIONEDUCATION DETECTION OF GLAUCOMA (NOT DETECTION OF GLAUCOMA (NOT
PROVEN)PROVEN) TESTS NOT SPECIFIC OR SENSITIVETESTS NOT SPECIFIC OR SENSITIVE
SCREENING- NO VALUE IF:SCREENING- NO VALUE IF:
NOT ABLE TO REFER FOR NOT ABLE TO REFER FOR DEFINITIVE DEFINITIVE DIAGNOSIS, DIAGNOSIS, TREATMENT AND TREATMENT AND FOLLOWUPFOLLOWUP
SCREENINGSCREENING CHOOSE HIGH RISK GROUPS E.G. CHOOSE HIGH RISK GROUPS E.G.
HISPANICS, BLACKS (OVER AGE 40, HISPANICS, BLACKS (OVER AGE 40, WHITES (OVER 65 YEARS OLD), WHITES (OVER 65 YEARS OLD), HISTORY OF EYE TRAUMA; HISTORY OF EYE TRAUMA; DIABETICS; DIABETICS;
FAMILY HISTORY OF GLAUCOMAFAMILY HISTORY OF GLAUCOMA DIABETICSDIABETICS PATIENTS WITH SEVERE MYOPIAPATIENTS WITH SEVERE MYOPIA
INTRAOCULAR INTRAOCULAR PRESSUREPRESSURE VERY EASY TO DO- PORTABLE VERY EASY TO DO- PORTABLE
INSTRUMENTSINSTRUMENTS POOR SENSITIVITY AND SPECIFICITYPOOR SENSITIVITY AND SPECIFICITY NORMAL- 20 mmHg OR LESSNORMAL- 20 mmHg OR LESS MEASURED BY: APPLANATION MEASURED BY: APPLANATION
TONOMETER- NOT PRACTICALTONOMETER- NOT PRACTICAL FINGER PALPATION- INACCURATEFINGER PALPATION- INACCURATE
APPLANATION TONOMETRY
SCHIOTZ TONOMETERSCHIOTZ TONOMETER
ADVANTAGES:ADVANTAGES:
INEXPENSIVEINEXPENSIVE
PORTABLEPORTABLE
EASY TO USEEASY TO USE
READILY AVAILABLEREADILY AVAILABLE
DISADVANTAGES:DISADVANTAGES:
NOT THE MOST NOT THE MOST ACCURATEACCURATE
REQUIRES TOPICAL REQUIRES TOPICAL ANESTHETICANESTHETIC
OPHTHALMOSCOPYOPHTHALMOSCOPY EASY; QUICKEASY; QUICK REQUIRES OPHTHALMOSCOPE- AVAILABLEREQUIRES OPHTHALMOSCOPE- AVAILABLE REQUIRES EXPERT AT OPHTHALMOSCOPYREQUIRES EXPERT AT OPHTHALMOSCOPY PICKS UP DEFINITIVE GLAUCOMA ( A LATE PICKS UP DEFINITIVE GLAUCOMA ( A LATE
STAGE)- MAY BE TOO LATE TO HAVE MUCH STAGE)- MAY BE TOO LATE TO HAVE MUCH BENEFITBENEFIT
INTER-OBSERVER VARIABILITYINTER-OBSERVER VARIABILITY NORMAL C:D RATIO- 0.3 OR LESS THAN 0.2 NORMAL C:D RATIO- 0.3 OR LESS THAN 0.2
DIFFERENCEDIFFERENCE (STEREO VIEWS ARE BEST (NOT PRACTICAL)(STEREO VIEWS ARE BEST (NOT PRACTICAL)
PERIPHERAL VISUAL FIELD PERIPHERAL VISUAL FIELD TESTINGTESTING
PICKS UP LATER GLAUCOMAPICKS UP LATER GLAUCOMA REQUIRES EXPENSIVE EQUIPMENT- REQUIRES EXPENSIVE EQUIPMENT-
DIFFICULT TO PERFORM- NOT DIFFICULT TO PERFORM- NOT PRACTICAL FOR SCREENINGPRACTICAL FOR SCREENING
OPTIC NERVE ANALYSIS- PICKS UP OPTIC NERVE ANALYSIS- PICKS UP PROBLEMS EARLIER (REQUIRES PROBLEMS EARLIER (REQUIRES EXPENSIVE EQUIPMENT AND EXPENSIVE EQUIPMENT AND TECHNNICAL SUPPORT)- NOT TECHNNICAL SUPPORT)- NOT PRACTICAL FOR SCREENINGPRACTICAL FOR SCREENING
REFERRALREFERRAL SET CRITERIA FOR EACH SCREENINGSET CRITERIA FOR EACH SCREENING E.G PRESSURE OVER 20 MM hGE.G PRESSURE OVER 20 MM hG INDIVIDUALS WITH SUSPICIOUS INDIVIDUALS WITH SUSPICIOUS
DISCS (LARGE CUPS)DISCS (LARGE CUPS) OPTIC NERVE- HEMORRHAGES; OPTIC NERVE- HEMORRHAGES;
LARGE CUP:DISC RATIO (OVER 0.4) LARGE CUP:DISC RATIO (OVER 0.4) OR ASYMMETRY OF CUPS OR ASYMMETRY OF CUPS (HORIZONTAL AND VERTICAL (HORIZONTAL AND VERTICAL CUP:DISC RATIO)- 0.3 DIFFERENCECUP:DISC RATIO)- 0.3 DIFFERENCE
BEST SCREENINGBEST SCREENING
COMPREHENSIVE EYE EXAM IN COMPREHENSIVE EYE EXAM IN OFFICE SETTING- BY OFFICE SETTING- BY SPECIALISTSPECIALIST
ADDITIONAL SCREENING ADDITIONAL SCREENING BENEFITSBENEFITS
POSSIBLY MORE IMPORTANT THAN POSSIBLY MORE IMPORTANT THAN DIAGNOSING GLAUCOMADIAGNOSING GLAUCOMA
EDUCATION OF NEED FOR EYE CAREEDUCATION OF NEED FOR EYE CARE OPHTHALMOSCOPIC EXAM WILL OPHTHALMOSCOPIC EXAM WILL
PICK UP:PICK UP: CATARACTSCATARACTS CORNEAL SCARSCORNEAL SCARS RETINAL DISEASE- DIABETES, RETINAL DISEASE- DIABETES,
HYPERTENSION, TUMORSHYPERTENSION, TUMORS
TREATMENT OF GLAUCOMATREATMENT OF GLAUCOMA
MEDICATIONS- MANY NEW MEDICATIONS- MEDICATIONS- MANY NEW MEDICATIONS- POTENTIAL SIDE-EFFECTSPOTENTIAL SIDE-EFFECTS
ONCE A DAY DOSAGE- BEST COMPLIANCEONCE A DAY DOSAGE- BEST COMPLIANCE TREAT EARLIERTREAT EARLIER LASER OR SURGERY- EARLIER ????- BEING LASER OR SURGERY- EARLIER ????- BEING
EVALUATEDEVALUATED WHICH FIRST? – BEING EVALUATEDWHICH FIRST? – BEING EVALUATED NEW PROCEDURESNEW PROCEDURES GOAL- < 20mmHg. (LOWER IN MANY SITUATIONS)GOAL- < 20mmHg. (LOWER IN MANY SITUATIONS)
SUMMARYSUMMARY GLAUCOMA SCREENINGGLAUCOMA SCREENING QUESTIONNABLE BENEFIT FOR QUESTIONNABLE BENEFIT FOR
PREVENTING BLINDNESSPREVENTING BLINDNESS WILL PICK UP A NUMBER OF CASES WILL PICK UP A NUMBER OF CASES
GLAUCOMA AND OTHER EYE CONDITIONSGLAUCOMA AND OTHER EYE CONDITIONS CONCENTRATE ON HIGH-RISK GROUPSCONCENTRATE ON HIGH-RISK GROUPS EASY TO DOEASY TO DO MARKED EDUCATIONAL AND PUBLIC MARKED EDUCATIONAL AND PUBLIC
RELATIONS BENEFITRELATIONS BENEFIT